Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience

Transplant Proc. 1996 Apr;28(2):1002-4.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antilymphocyte Serum / therapeutic use
  • Azathioprine / therapeutic use
  • Communicable Diseases / epidemiology
  • Coronary Disease / epidemiology
  • Cyclosporine / therapeutic use*
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Heart Transplantation / immunology
  • Heart Transplantation / mortality
  • Heart Transplantation / physiology*
  • Humans
  • Hypertension / chemically induced
  • Hypertension / epidemiology
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Incidence
  • Muromonab-CD3 / therapeutic use
  • Prednisone / therapeutic use
  • Survival Rate
  • Tacrolimus / adverse effects
  • Tacrolimus / therapeutic use*
  • Time Factors
  • Transplantation, Homologous

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Cyclosporine
  • Azathioprine
  • Prednisone
  • Tacrolimus